Hadassah

Dr. Hadas Mechoulam: Saving the Sight of Babies

Thursday, Apr 23 2015

Dr. Hadas Mechoulam

Dr. Hadas Mechoulam, pediatric ophthalmologist at Hadassah Medical Organization (HMO), has made it her mission to retain the sight of premature babies from Nablus.

Premature babies are born with immature blood vessel or retinas. In countries like Israel, they receive early intervention to ensure that this will not affect their vision. Unscreened infants can go on to develop retinal detachment which causes blindness.

A few years ago, Dr. Mechoulam operated on 20 such infants from Nablus at HMO. Now she is working with Palestinian physicians to screen and treat infants with the condition before their vision worsens. She has already taught her Palestinian colleagues how to give simple injections that will help the retina mature, with plans to train these physicians to implement more advanced screening methods and interventions in the future.

Dr. Mechoulam is also arranging a small conference in Jericho with Palestinian neonatologists, ophthalmologists, and nurses, where Israeli neonatal ophthalmologists will share their knowledge about risk factors and treatment of these infants. Also on her “wish list” is to bring a group of blind babies from Gaza to HMO for treatment. “Getting them here,” says Dr. Mechoulam, “is probably the most complicated part.”

Comments

From: Karen on July 8, 2015
Dr. Mechoulam and Hadassah are miracle workers and peace activists in a region which needs more of both.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More